<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Shen L</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The objective of this study was to assess the accuracy of FreeStyle Libre Pro (FSL-Pro) flash continuous glucose monitoring (CGM) in patients with type 2 diabetes mellitus (T2DM) and acute myocardial infarction (AMI).&lt;h4>Methods&lt;/h4>A single-arm, single-center prospective study was conducted in the cardiac care unit from January 2021 to September 2023. Patients underwent finger-prick blood glucose (FPBG) testing before breakfast (6:00 am) and after meals (at 9:00, 13:00, 19:00 pm), along with CGM during their hospitalization. Statistical analyses included mean differences (MDs), mean absolute relative difference (MARDs) of blood glucose levels, and hypoglycemia occurrences. A Bland-Altman plot analysis and Pearson correlation were performed.&lt;h4>Results&lt;/h4>Ninety-seven T2DM</pubmed_abstract><journal>Digital health</journal><pagination>20552076241287842</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11456750</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Breaking through diabetes management barriers: Assessing the accuracy of Freestyle Libre Pro flash continuous glucose monitoring in diabetes patients with myocardial infarction.</pubmed_title><pmcid>PMC11456750</pmcid><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Shen L</pubmed_authors><pubmed_authors>Cao MJ</pubmed_authors><pubmed_authors>Shi FH</pubmed_authors><pubmed_authors>Jing XT</pubmed_authors><pubmed_authors>Pu J</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Gong WW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Breaking through diabetes management barriers: Assessing the accuracy of Freestyle Libre Pro flash continuous glucose monitoring in diabetes patients with myocardial infarction.</name><description>&lt;h4>Purpose&lt;/h4>The objective of this study was to assess the accuracy of FreeStyle Libre Pro (FSL-Pro) flash continuous glucose monitoring (CGM) in patients with type 2 diabetes mellitus (T2DM) and acute myocardial infarction (AMI).&lt;h4>Methods&lt;/h4>A single-arm, single-center prospective study was conducted in the cardiac care unit from January 2021 to September 2023. Patients underwent finger-prick blood glucose (FPBG) testing before breakfast (6:00 am) and after meals (at 9:00, 13:00, 19:00 pm), along with CGM during their hospitalization. Statistical analyses included mean differences (MDs), mean absolute relative difference (MARDs) of blood glucose levels, and hypoglycemia occurrences. A Bland-Altman plot analysis and Pearson correlation were performed.&lt;h4>Results&lt;/h4>Ninety-seven T2DM</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan-Dec</publication><modification>2025-04-26T20:18:31.445Z</modification><creation>2025-04-06T16:26:27.335Z</creation></dates><accession>S-EPMC11456750</accession><cross_references><pubmed>39376945</pubmed><doi>10.1177/20552076241287842</doi></cross_references></HashMap>